• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»biologics discovery

Chai Discovery tests a new commercial route for AI-designed biologics through Lilly TuneLab

By Pallavi Madhiraju on June 21, 2026   Pharma & Biotech  

Chai Discovery tests a new commercial route for AI-designed biologics through Lilly TuneLab

Explore how Chai Discovery and Lilly TuneLab are widening biotech access to AI miniprotein design and what must happen next.

AI can design proteins faster than labs can test them. LenioBio and Twist want to fix that bottleneck

By Pallavi Madhiraju on May 9, 2026   Pharma & Biotech  

AI can design proteins faster than labs can test them. LenioBio and Twist want to fix that bottleneck

AI can design proteins fast. Biology still sets the pace. LenioBio and Twist Bioscience are targeting drug discovery’s validation gap.

Recent Posts

  • Why Premier Biotech’s NexScreen and TransMed acquisitions could reshape rapid drug testing
  • Chai Discovery tests a new commercial route for AI-designed biologics through Lilly TuneLab
  • Why Veraxa Biotech stock fell 23% after its BiTAC-ADC proof-of-concept data
  • Greenstone Biosciences and Intel chase faster drug discovery as regulators back human-relevant models
  • Why AngioDynamics stock investors should watch NanoKnife’s move into benign prostate disease
  • Canada’s healthcare market faces a turning point as Alberta prepares dual-practice surgery launch
  • AbbVie nears reported $10.9bn Apogee deal as zumilokibart heads toward Phase 3
  • Memo Therapeutics advances potravitug as the race for the first BK virus therapy intensifies
  • CureGene targets clopidogrel variability as evategrel begins a critical United States study
  • GSK and Spero win Utebzi approval after an earlier FDA rejection and new Phase 3 trial
  • Can uniQure turn the FDA’s AMT-130 reversal into a Huntington’s disease approval?
  • Replicate Bioscience wins Gates Foundation support for an ambitious TB vaccine strategy
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes